5th Edition of International Heart Congress
June 24-26, 2027 | Hybrid Event
Heart Congress 2023
Title: Brf1, A potential therapeutic target of cardiovascular disease
Title: Cardiac fibroblast activation in the early stage of anthracycline cardiotoxicity
Title: Lipid-lowering therapies: Where are we now and where are we heading?
Title: Powering biopharma research with data and genomics in cardiology – spearhead of excellence
Title: Cardiometry: A new fundamental scientific field in cardiology
Title: The protective role of Nicotinamide Adenine Dinucleotide in diabetic cardiomyopathy from db/db mice.
Title: Automated interpretation of congenital heart disease from multi-view echocardiograms
Title: Nanotherapeutic strategies for the treatment of diabetes mellitus
Title: Accelerate mobilization & IN-patient rehabilitation program
Title: The study of cardiac troponin I in ST segment elevation myocardial infarction and its complications
Title: Anesthetic considerations of ASD with pulmonary arterial hypertension for non-cardiac surgery
Title: Personality assessment in substance users at the risk of cardiovascular comorbidity
Title: Ophthalmological complications of cardiovascular and other lifestyle diseases
Title: Role of spirometry,deep breathing and chest expansion in cardiac rehabilitation
Title: Cardiovascular thoracic rehabilitation and secondary prevention
Title: Phyician assistant training program for management of cardiovascular and thoracic patients
Title: Dietary guidelines for prevention of cardiovascular diseases
Title: Role of digital intervention in management of lifestyle diseases
Title: Role of whole-food plant based diet in improving cardiovascular health
Title: The impact of socioeconomic factors on hypertension and obesity: A systematic review.
Title: Epinephrine for managing no-reflow phenomenon: A systematic review
Title: ECG denoising based on WATV and convex fused lasso denoising with non-convex regularization
Title: Surgical resection of a massive mediastinal tumour with mass effect
Title: Impact of fcar methylation on susceptibility and coronary artery lesions in Kawasaki disease
